Regency Care Of Rogue Valley Medicare and Medicaid Location: 1710 Ne Fairview Avenue, Grants Pass, Oregon 97526 Ratings: Phone: (541) 479-2606 |
Royale Gardens Health & Rehabilitation Center Medicare and Medicaid Location: 2075 Nw Highland Avenue, Grants Pass, Oregon 97526 Ratings: Phone: (541) 476-8891 |
Highland House Nursing & Rehabilitation Center Medicare and Medicaid Location: 2201 Nw Highland Avenue, Grants Pass, Oregon 97526 Ratings: Phone: (541) 474-1901 |
Laurel Hill Nursing Center Medicare and Medicaid Location: 859 Ne 6th Street, Grants Pass, Oregon 97526 Ratings: Phone: (541) 479-3700 |
News Archive
With an economy that might cause some parents to postpone regular dental visits for their children and tooth decay being the most prevalent chronic disease in America's children, the American Dental Association (ADA) is mobilizing dental professionals for the eighth consecutive year in a national campaign to extend necessary care to children and adolescents from low-income families.
The presence of chemicals made as the body breaks down fats, proteins, and carbohydrates can predict whether Sept. 11, 2001 first responders exposed to toxic dust at the World Trade Center site subsequently develop lung disease, a new study finds.
Researchers from the Department of Psychiatry at the University of Cambridge recently identified a method of improving cognitive functioning in patients with schizophrenia, without the side-effects traditionally found with cognitive enhancers. Ms. Danielle Turner, together with colleagues from the University of Cambridge under the supervision of Prof. Barbara Sahakian, undertook research to explore the potential for a memory drug to improve cognition in patients with schizophrenia. The project received funding from the Wellcome Trust and the Medical Research Council. The work was published online on March 10 2004 at The American College of Neuropsychopharmacology website and is now in press in the journal Neuropsychopharmacology.
For the first time, researchers at the George Washington University, together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer.
› Verified 1 days ago